Selectis Health (GBCS) Revenue (2010 - 2025)

Selectis Health has disclosed Revenue across 12 years of filings, most recently posting $9.7 million for Q4 2025.

• Revenue for Q4 2025 came in at $9.7 million, down 6.98% year-over-year; the trailing twelve-month figure through Dec 2025 was $41.4 million (up 4.94% YoY), and the FY2025 annual result was $41.4 million, up 4.94% from the prior year.
• Revenue came in at $9.7 million for Q4 2025 at Selectis Health, down from $10.8 million in the prior quarter.
• In the past five years, Revenue ranged from a high of $11.5 million in Q2 2022 to a low of $5.8 million in Q1 2021.
• The 5-year median for Revenue is $9.6 million (2023), against an average of $9.4 million.
• Across the five-year window, Revenue surged 90.71% in 2022 and dropped 22.13% in 2023, its largest moves.
• Selectis Health's Revenue stood at $10.2 million in 2021, then advanced by 5.95% to $10.8 million in 2022, then retreated by 14.78% to $9.2 million in 2023, then rose by 12.99% to $10.4 million in 2024, then declined by 6.98% to $9.7 million in 2025.
• The last three Revenue figures came in at $9.7 million (Q4 2025), $10.8 million (Q3 2025), and $10.4 million (Q2 2025), per Business Quant data.